Grace Life-tech Holdings Limited

Grace Life-tech Holdings Limited

HHKEX:2112
0.03
HKD
+0.00
(-5.88%)
87.02MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.08
0.1
0.37
0.83
0.74
0.96
0.7
0.02
0.02
0.02
0.02
0.01
0.01
- -
Basic EPS, GAAP
0.02
- -
- -
- -
- -
- -
-0.04
-0.02
-0.04
-0.04
-0.03
-0.03
-0.01
- -
Free Cash Flow per Basic Share
-0.01
-0.01
- -
-0.01
-0.08
0.01
-0.01
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.07
0.06
0.06
0.07
0.07
0.1
0.06
0.02
-0.02
-0.05
-0.08
-0.11
-0.12
-0.12
Tangible Book Value per Share
0.05
0.06
0.05
0.06
0.07
0.1
0.05
0.02
-0.02
-0.06
-0.08
-0.12
-0.13
-0.13
Basic Weighted Avg Shares
1,311
1,500
1,500
1,500
1,500
1,500
1,500
1,500
1,500
1,500
1,500
1,500
1,500
1,500
Sales/Revenue/Turnover
110
152
550
1,241
1,105
1,447
1,055
28
24
32
27
14
13
- -
Operating Margin (%)
24.11
4.08
2.26
0.96
0.64
0.79
0.52
-17.35
-11.7
-10.86
-8.46
-7.7
-6.41
- -
Depreciation Expense
2
2
2
1
1
1
1
1
1
- -
- -
- -
- -
- -
Net Income, GAAP
20
2
1
4
3
3
-57
-30
-57
-56
-40
-48
-15
- -
Effective Tax Rate (%)
21.66
25.45
77.39
22.24
14.94
22.44
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
17.89
1.45
0.11
0.35
0.31
0.18
-5.41
-106.27
-237.74
-172.32
-145.17
-349.67
-118.2
- -
Working Capital
41
24
53
80
85
68
62
15
-41
-96
-134
-183
-197
-197
LT Debt
1
- -
- -
20
20
- -
- -
- -
- -
- -
- -
- -
1
1
Total Equity
104
95
94
103
108
153
90
34
-24
-80
-120
-167
-182
-182
Return on Invested Capital (%)
26.27
3.78
2.14
6.18
2.8
3.54
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
29.15
2.36
0.56
4.57
3.82
4.17
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
30.2
2.21
0.65
4.42
3.25
1.96
-47.62
-48.23
- -
- -
- -
- -
- -
- -

Capital Structure

USD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
133
140
148
LT Borrowings
- -
- -
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,500
1,500
1,500
Market Capitalization
22
11
11

Working Capital

USD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
61
62
55
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
59
59
52
Inventories
1
1
1
Total Current Liabilities
244
244
253
Payables & Accruals
- -
- -
- -
ST Debt
133
140
148
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.98%
31.39%
8.44%
Free Cash Flow
96.52%
-16.13%
348.72%
Net Income, GAAP
-182.99%
3.01%
-67.93%
Sales/Revenue/Turnover
-2.83%
-9.87%
-5.11%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
27
2024
- -
- -
14
2025
- -
- -
13

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.03
2024
- -
- -
-0.03
2025
- -
- -
-0.01

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

CEO
Khing Yeu Ng
Full Time Employees
49
Sector
Distribution services
Industry
Wholesale distributors
Address
Lot 22, D&E Kuantan PA Malaysia 25200
IPO Date
Jul 3, 2013
Business
Grace Life-tech Holdings Limited, founded in 2007 and headquartered in Hong Kong, is an investment holding company primarily engaged in the research, development, and application of plant stem cell technology with diversified operations spanning health solutions, iron ore mining, commercial trade, and electronics. The company’s core products and services include plant stem cell-based health products such as anti-aging skincare, oral nutritional supplements, and precision medical-grade plant active ingredient products targeting chronic disease management, immune enhancement, metabolic improvement, and cardiovascular health. It also offers functional fast-moving consumer goods (FMCG) beverages like Seuyuan Ginseng Beverage and Sweet Tea Ginseng Tissue Culture Beverage. Additionally, it conducts iron ore mining and processing operations in Malaysia, trades crude oil and other commodities, trades health and electronic products, and develops water purification and soil remediation products leveraging biotechnology applications. In the past two years, Grace Life-tech Holdings has pursued a strategic shift towards biotechnological innovation and health product development, expanding into traditional Chinese medicine production bases that integrate plant stem cell technology with TCM concepts for high-quality health products. The company has strengthened its research and development capabilities, launched competitive plant stem cell products, and accelerated patent applications related to extraction and application technologies. It has also expanded market reach through diversified distribution channels, including planning to deploy 10,000 automated vending machines nationwide across China and establishing over 50 plant stem cell health management centers. The company continues to focus on sustainability, industrial advancement, and innovation in its core sectors to consolidate market share. However, its iron ore business faced profitability challenges in 2024 due to declining iron ore prices. Grace Life-tech operates across Hong Kong, mainland China, Malaysia, and internationally, with business segments encompassing Iron Ore Mining and Processing, Commercial Trade, Health Products Trade, Electronic Products Trade, and Others. The company transitioned from its former name CAA Resources Limited and is actively pursuing sustainable growth by integrating modern biotechnology with traditional health product markets while maintaining its commodity trading and mining operations.